ArticleInorganic chemistry2026
One Scaffold, Three Chelation Modes: 2-(1H-Tetrazol-1-yl)pyridine as a Dynamic Ligand for Cationic and Neutral Cyclometalated Iridium(III) Complexes.
Article in Inorganic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The 2-(1H-tetrazol-1-yl)pyridine scaffold (L1) is exploited as a versatile ligand in heteroleptic iridium(III) complexes. Depending on the reaction conditions, ligand L1 reacts with the prototypical iridium(III) dimer [Ir(ppy)2(μ-Cl)]2 (where Hppy = 2-phenylpyridine) leading to the formation of distinct complexes. As a neutral N∧N ancillary ligand, it forms the cationic complex A, otherwise, after deprotonation of its tetrazole ring, as a monoanionic C∧N ligand it can lead the neutral complex B. Finally, after N-methylation to form the tetrazolium salt L2, it behaves as a N-heterocyclic carbene (N∧C: chelation mode), forming the cationic complex C. This trimodal coordination versatility is further enriched by the serendipitous discovery of the byproduct complex D, arising from partial ring-opening of the tetrazolium salt. The electrochemical redox gap of the complexes reflects the different σ-donor and π-acceptor character of each coordination mode. Complex A shows a broad metal-to-ligand charge-transfer (3MLCT) emission band at 298 K, while complexes B-D display an intricate interplay between ligand-centered (3LC) and 3MLCT states, as confirmed by DFT calculations. This work establishes a novel class of multifunctional ligands and provides a comprehensive structure-property investigation for improving the photophysical performances of tetrazole-based iridium(III) emitters for optoelectronic applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.